Maximus, Inc. (NYSE:MMS) Shares Purchased by Xponance Inc.

Xponance Inc. increased its stake in Maximus, Inc. (NYSE:MMS) by 4.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,526 shares of the health services provider’s stock after acquiring an additional 336 shares during the period. Xponance Inc.’s holdings in Maximus were worth $636,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its holdings in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after buying an additional 158 shares during the period. Eastern Bank bought a new position in shares of Maximus during the 4th quarter valued at about $29,000. V Square Quantitative Management LLC grew its stake in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd bought a new stake in shares of Maximus in the 4th quarter worth approximately $54,000. Finally, IFP Advisors Inc lifted its stake in Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Insider Activity

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company’s stock, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd.

Maximus Price Performance

Shares of MMS opened at $66.39 on Wednesday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The firm has a market cap of $3.76 billion, a PE ratio of 14.28 and a beta of 0.71. The firm’s 50 day moving average price is $70.64 and its 200 day moving average price is $78.17. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.81%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.